 | • レポートコード：QAF27602 • 出版社/出版日：QYResearch / 2021年3月31日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のがん治療薬市場について種類別（化学療法、標的療法、免疫療法、ホルモン療法（生物学的療法）、その他）、用途別（血液がん、乳がん、胃腸がん、前立腺がん、呼吸器・肺がん、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・がん治療薬市場の概要 ・世界の主要地域別がん治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のがん治療薬市場規模2016-2021：種類別（化学療法、標的療法、免疫療法、ホルモン療法（生物学的療法）、その他） ・世界のがん治療薬市場予測2012-2027：種類別（化学療法、標的療法、免疫療法、ホルモン療法（生物学的療法）、その他） ・世界のがん治療薬市場規模2016-2021：用途別（血液がん、乳がん、胃腸がん、前立腺がん、呼吸器・肺がん、その他） ・世界のがん治療薬市場予測2012-2027：用途別（血液がん、乳がん、胃腸がん、前立腺がん、呼吸器・肺がん、その他） ・がん治療薬のアメリカ市場規模と予測2016-2021 ・がん治療薬のヨーロッパ市場規模と予測2016-2021 ・がん治療薬の中国市場規模と予測2016-2021 ・がん治療薬の日本市場規模と予測2016-2021 ・がん治療薬の東南アジア市場規模と予測2016-2021 ・がん治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Novartis、Celgene、Bristol-Myers Squibb、Amgen、Johnson & Johnson、Pfizer、Takeda、Eli Lilly、AstraZeneca、Astellas、Merck & Co.、Sanofi、Bayer、Biogen Idec、Eisai、Teva、Otsuka、Merck KGaA、Ipsen、AbbVie、Gilead Sciences） ・がん治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・がん治療薬の市場動向・機会・課題 ・調査の結論 |
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
Market Analysis and Insights: Global Cancer Treatment Drugs Market
The global Cancer Treatment Drugs market was valued at US$ 179750 in 2020 and will reach US$ 298160 million by the end of 2027, growing at a CAGR of 8.8% during 2022-2027.
Global Cancer Treatment Drugs Scope and Market Size
The global Cancer Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others
The Cancer Treatment Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Cancer Treatment Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
1 Cancer Treatment Drugs Market Overview
1.1 Cancer Treatment Drugs Product Scope
1.2 Cancer Treatment Drugs Segment by Type
1.2.1 Global Cancer Treatment Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Cancer Treatment Drugs Segment by Application
1.3.1 Global Cancer Treatment Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Others
1.4 Cancer Treatment Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Cancer Treatment Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Cancer Treatment Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Cancer Treatment Drugs Price Trends (2016-2027)
2 Cancer Treatment Drugs Estimates and Forecasts by Region
2.1 Global Cancer Treatment Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Cancer Treatment Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Cancer Treatment Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Cancer Treatment Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Cancer Treatment Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Cancer Treatment Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Cancer Treatment Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Cancer Treatment Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Cancer Treatment Drugs Estimates and Projections (2016-2027)
2.4.3 China Cancer Treatment Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Cancer Treatment Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Cancer Treatment Drugs Estimates and Projections (2016-2027)
2.4.6 India Cancer Treatment Drugs Estimates and Projections (2016-2027)
3 Global Cancer Treatment Drugs Competition Landscape by Players
3.1 Global Top Cancer Treatment Drugs Players by Sales (2016-2021)
3.2 Global Top Cancer Treatment Drugs Players by Revenue (2016-2021)
3.3 Global Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Treatment Drugs as of 2020)
3.4 Global Cancer Treatment Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Cancer Treatment Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Cancer Treatment Drugs Market Size by Type
4.1 Global Cancer Treatment Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Cancer Treatment Drugs Price by Type (2016-2021)
4.2 Global Cancer Treatment Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Cancer Treatment Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Cancer Treatment Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Cancer Treatment Drugs Price Forecast by Type (2022-2027)
5 Global Cancer Treatment Drugs Market Size by Application
5.1 Global Cancer Treatment Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Cancer Treatment Drugs Price by Application (2016-2021)
5.2 Global Cancer Treatment Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Cancer Treatment Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Cancer Treatment Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Cancer Treatment Drugs Price Forecast by Application (2022-2027)
6 North America Cancer Treatment Drugs Market Facts & Figures
6.1 North America Cancer Treatment Drugs Sales by Company
6.1.1 North America Cancer Treatment Drugs Sales by Company (2016-2021)
6.1.2 North America Cancer Treatment Drugs Revenue by Company (2016-2021)
6.2 North America Cancer Treatment Drugs Sales Breakdown by Type
6.2.1 North America Cancer Treatment Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Cancer Treatment Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Cancer Treatment Drugs Sales Breakdown by Application
6.3.1 North America Cancer Treatment Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Cancer Treatment Drugs Sales Breakdown by Application (2022-2027)
7 Europe Cancer Treatment Drugs Market Facts & Figures
7.1 Europe Cancer Treatment Drugs Sales by Company
7.1.1 Europe Cancer Treatment Drugs Sales by Company (2016-2021)
7.1.2 Europe Cancer Treatment Drugs Revenue by Company (2016-2021)
7.2 Europe Cancer Treatment Drugs Sales Breakdown by Type
7.2.1 Europe Cancer Treatment Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Cancer Treatment Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Cancer Treatment Drugs Sales Breakdown by Application
7.3.1 Europe 141 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 141 Sales Breakdown by Application (2022-2027)
8 China Cancer Treatment Drugs Market Facts & Figures
8.1 China Cancer Treatment Drugs Sales by Company
8.1.1 China Cancer Treatment Drugs Sales by Company (2016-2021)
8.1.2 China Cancer Treatment Drugs Revenue by Company (2016-2021)
8.2 China Cancer Treatment Drugs Sales Breakdown by Type
8.2.1 China Cancer Treatment Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Cancer Treatment Drugs Sales Breakdown by Type (2022-2027)
8.3 China Cancer Treatment Drugs Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Cancer Treatment Drugs Market Facts & Figures
9.1 Japan Cancer Treatment Drugs Sales by Company
9.1.1 Japan Cancer Treatment Drugs Sales by Company (2016-2021)
9.1.2 Japan Cancer Treatment Drugs Revenue by Company (2016-2021)
9.2 Japan Cancer Treatment Drugs Sales Breakdown by Type
9.2.1 Japan Cancer Treatment Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Cancer Treatment Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Cancer Treatment Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Cancer Treatment Drugs Market Facts & Figures
10.1 Southeast Asia Cancer Treatment Drugs Sales by Company
10.1.1 Southeast Asia Cancer Treatment Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Cancer Treatment Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Cancer Treatment Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Cancer Treatment Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Cancer Treatment Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Cancer Treatment Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Cancer Treatment Drugs Market Facts & Figures
11.1 India Cancer Treatment Drugs Sales by Company
11.1.1 India Cancer Treatment Drugs Sales by Company (2016-2021)
11.1.2 India Cancer Treatment Drugs Revenue by Company (2016-2021)
11.2 India Cancer Treatment Drugs Sales Breakdown by Type
11.2.1 India Cancer Treatment Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Cancer Treatment Drugs Sales Breakdown by Type (2022-2027)
11.3 India Cancer Treatment Drugs Sales Breakdown by Application
11.3.1 India Cancer Treatment Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Cancer Treatment Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Cancer Treatment Drugs Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Cancer Treatment Drugs Products Offered
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Cancer Treatment Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Corporation Information
12.3.2 Celgene Business Overview
12.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Celgene Cancer Treatment Drugs Products Offered
12.3.5 Celgene Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Business Overview
12.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Business Overview
12.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amgen Cancer Treatment Drugs Products Offered
12.5.5 Amgen Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Johnson & Johnson Cancer Treatment Drugs Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Cancer Treatment Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 Takeda
12.8.1 Takeda Corporation Information
12.8.2 Takeda Business Overview
12.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Takeda Cancer Treatment Drugs Products Offered
12.8.5 Takeda Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Business Overview
12.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly Cancer Treatment Drugs Products Offered
12.9.5 Eli Lilly Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Corporation Information
12.10.2 AstraZeneca Business Overview
12.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 AstraZeneca Cancer Treatment Drugs Products Offered
12.10.5 AstraZeneca Recent Development
12.11 Astellas
12.11.1 Astellas Corporation Information
12.11.2 Astellas Business Overview
12.11.3 Astellas Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Astellas Cancer Treatment Drugs Products Offered
12.11.5 Astellas Recent Development
12.12 Merck & Co.
12.12.1 Merck & Co. Corporation Information
12.12.2 Merck & Co. Business Overview
12.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Merck & Co. Cancer Treatment Drugs Products Offered
12.12.5 Merck & Co. Recent Development
12.13 Sanofi
12.13.1 Sanofi Corporation Information
12.13.2 Sanofi Business Overview
12.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sanofi Cancer Treatment Drugs Products Offered
12.13.5 Sanofi Recent Development
12.14 Bayer
12.14.1 Bayer Corporation Information
12.14.2 Bayer Business Overview
12.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Bayer Cancer Treatment Drugs Products Offered
12.14.5 Bayer Recent Development
12.15 Biogen Idec
12.15.1 Biogen Idec Corporation Information
12.15.2 Biogen Idec Business Overview
12.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Biogen Idec Cancer Treatment Drugs Products Offered
12.15.5 Biogen Idec Recent Development
12.16 Eisai
12.16.1 Eisai Corporation Information
12.16.2 Eisai Business Overview
12.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Eisai Cancer Treatment Drugs Products Offered
12.16.5 Eisai Recent Development
12.17 Teva
12.17.1 Teva Corporation Information
12.17.2 Teva Business Overview
12.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Teva Cancer Treatment Drugs Products Offered
12.17.5 Teva Recent Development
12.18 Otsuka
12.18.1 Otsuka Corporation Information
12.18.2 Otsuka Business Overview
12.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Otsuka Cancer Treatment Drugs Products Offered
12.18.5 Otsuka Recent Development
12.19 Merck KGaA
12.19.1 Merck KGaA Corporation Information
12.19.2 Merck KGaA Business Overview
12.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Merck KGaA Cancer Treatment Drugs Products Offered
12.19.5 Merck KGaA Recent Development
12.20 Ipsen
12.20.1 Ipsen Corporation Information
12.20.2 Ipsen Business Overview
12.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Ipsen Cancer Treatment Drugs Products Offered
12.20.5 Ipsen Recent Development
12.21 AbbVie
12.21.1 AbbVie Corporation Information
12.21.2 AbbVie Business Overview
12.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.21.4 AbbVie Cancer Treatment Drugs Products Offered
12.21.5 AbbVie Recent Development
12.22 Gilead Sciences
12.22.1 Gilead Sciences Corporation Information
12.22.2 Gilead Sciences Business Overview
12.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Gilead Sciences Cancer Treatment Drugs Products Offered
12.22.5 Gilead Sciences Recent Development
13 Cancer Treatment Drugs Manufacturing Cost Analysis
13.1 Cancer Treatment Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cancer Treatment Drugs
13.4 Cancer Treatment Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cancer Treatment Drugs Distributors List
14.3 Cancer Treatment Drugs Customers
15 Market Dynamics
15.1 Cancer Treatment Drugs Market Trends
15.2 Cancer Treatment Drugs Drivers
15.3 Cancer Treatment Drugs Market Challenges
15.4 Cancer Treatment Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cancer Treatment Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Cancer Treatment Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Cancer Treatment Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Cancer Treatment Drugs Sales (K Pcs) by Region (2016-2021)
Table 5. Global Cancer Treatment Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Cancer Treatment Drugs Revenue Share by Region (2016-2021)
Table 8. Global Cancer Treatment Drugs Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Cancer Treatment Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Cancer Treatment Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Cancer Treatment Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Cancer Treatment Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Cancer Treatment Drugs Sales Share by Company (2016-2021)
Table 14. Global Cancer Treatment Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Cancer Treatment Drugs Revenue Share by Company (2016-2021)
Table 16. Global Cancer Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Treatment Drugs as of 2020)
Table 17. Global Cancer Treatment Drugs Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Cancer Treatment Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Cancer Treatment Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Cancer Treatment Drugs Sales (K Pcs) by Type (2016-2021)
Table 22. Global Cancer Treatment Drugs Sales Share by Type (2016-2021)
Table 23. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Cancer Treatment Drugs Sales Share by Type (2022-2027)
Table 26. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Cancer Treatment Drugs Revenue Share by Type (2022-2027)
Table 28. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2016-2021)
Table 30. Global Cancer Treatment Drugs Sales Share by Application (2016-2021)
Table 31. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2022-2027)
Table 34. Global Cancer Treatment Drugs Sales Share by Application (2022-2027)
Table 35. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Cancer Treatment Drugs Revenue Share by Application (2022-2027)
Table 37. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Cancer Treatment Drugs Sales (K Pcs) by Company (2016-2021)
Table 39. North America Cancer Treatment Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Cancer Treatment Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Cancer Treatment Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Cancer Treatment Drugs Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Cancer Treatment Drugs Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Cancer Treatment Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Cancer Treatment Drugs Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Cancer Treatment Drugs Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Cancer Treatment Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Cancer Treatment Drugs Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Cancer Treatment Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Cancer Treatment Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Cancer Treatment Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Cancer Treatment Drugs Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Cancer Treatment Drugs Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Cancer Treatment Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Cancer Treatment Drugs Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Cancer Treatment Drugs Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Cancer Treatment Drugs Sales Market Share by Application (2022-2027)
Table 62. China Cancer Treatment Drugs Sales (K Pcs) by Company (2016-2021)
Table 63. China Cancer Treatment Drugs Sales Market Share by Company (2016-2021)
Table 64. China Cancer Treatment Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Cancer Treatment Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Cancer Treatment Drugs Sales by Type (2016-2021) & (K Pcs)
Table 67. China Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
Table 68. China Cancer Treatment Drugs Sales by Type (2022-2027) & (K Pcs)
Table 69. China Cancer Treatment Drugs Sales Market Share by Type (2022-2027)
Table 70. China Cancer Treatment Drugs Sales by Application (2016-2021) & (K Pcs)
Table 71. China Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
Table 72. China Cancer Treatment Drugs Sales by Application (2022-2027) & (K Pcs)
Table 73. China Cancer Treatment Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Cancer Treatment Drugs Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Cancer Treatment Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Cancer Treatment Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Cancer Treatment Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Cancer Treatment Drugs Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Cancer Treatment Drugs Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Cancer Treatment Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Cancer Treatment Drugs Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Cancer Treatment Drugs Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Cancer Treatment Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Cancer Treatment Drugs Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Cancer Treatment Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Cancer Treatment Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Cancer Treatment Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Cancer Treatment Drugs Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Cancer Treatment Drugs Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Cancer Treatment Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Cancer Treatment Drugs Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Cancer Treatment Drugs Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Cancer Treatment Drugs Sales Market Share by Application (2022-2027)
Table 98. India Cancer Treatment Drugs Sales (K Pcs) by Company (2016-2021)
Table 99. India Cancer Treatment Drugs Sales Market Share by Company (2016-2021)
Table 100. India Cancer Treatment Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Cancer Treatment Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Cancer Treatment Drugs Sales by Type (2016-2021) & (K Pcs)
Table 103. India Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
Table 104. India Cancer Treatment Drugs Sales by Type (2022-2027) & (K Pcs)
Table 105. India Cancer Treatment Drugs Sales Market Share by Type (2022-2027)
Table 106. India Cancer Treatment Drugs Sales by Application (2016-2021) & (K Pcs)
Table 107. India Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
Table 108. India Cancer Treatment Drugs Sales by Application (2022-2027) & (K Pcs)
Table 109. India Cancer Treatment Drugs Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Roche Cancer Treatment Drugs Product
Table 114. Roche Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Novartis Cancer Treatment Drugs Product
Table 119. Novartis Recent Development
Table 120. Celgene Corporation Information
Table 121. Celgene Description and Business Overview
Table 122. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Celgene Cancer Treatment Drugs Product
Table 124. Celgene Recent Development
Table 125. Bristol-Myers Squibb Corporation Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Bristol-Myers Squibb Cancer Treatment Drugs Product
Table 129. Bristol-Myers Squibb Recent Development
Table 130. Amgen Corporation Information
Table 131. Amgen Description and Business Overview
Table 132. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Amgen Cancer Treatment Drugs Product
Table 134. Amgen Recent Development
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Johnson & Johnson Cancer Treatment Drugs Product
Table 139. Johnson & Johnson Recent Development
Table 140. Pfizer Corporation Information
Table 141. Pfizer Description and Business Overview
Table 142. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Pfizer Cancer Treatment Drugs Product
Table 144. Pfizer Recent Development
Table 145. Takeda Corporation Information
Table 146. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Takeda Description and Business Overview
Table 148. Takeda Cancer Treatment Drugs Product
Table 149. Takeda Recent Development
Table 150. Eli Lilly Corporation Information
Table 151. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Eli Lilly Description and Business Overview
Table 153. Eli Lilly Cancer Treatment Drugs Product
Table 154. Eli Lilly Recent Development
Table 155. AstraZeneca Corporation Information
Table 156. AstraZeneca Description and Business Overview
Table 157. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. AstraZeneca Cancer Treatment Drugs Product
Table 159. AstraZeneca Recent Development
Table 160. Astellas Corporation Information
Table 161. Astellas Description and Business Overview
Table 162. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Astellas Cancer Treatment Drugs Product
Table 164. Astellas Recent Development
Table 165. Merck & Co. Corporation Information
Table 166. Merck & Co. Description and Business Overview
Table 167. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Merck & Co. Cancer Treatment Drugs Product
Table 169. Merck & Co. Recent Development
Table 170. Sanofi Corporation Information
Table 171. Sanofi Description and Business Overview
Table 172. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Sanofi Cancer Treatment Drugs Product
Table 174. Sanofi Recent Development
Table 175. Bayer Corporation Information
Table 176. Bayer Description and Business Overview
Table 177. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Bayer Cancer Treatment Drugs Product
Table 179. Bayer Recent Development
Table 180. Biogen Idec Corporation Information
Table 181. Biogen Idec Description and Business Overview
Table 182. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Biogen Idec Cancer Treatment Drugs Product
Table 184. Biogen Idec Recent Development
Table 185. Eisai Corporation Information
Table 186. Eisai Description and Business Overview
Table 187. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Eisai Cancer Treatment Drugs Product
Table 189. Eisai Recent Development
Table 190. Teva Corporation Information
Table 191. Teva Description and Business Overview
Table 192. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Teva Cancer Treatment Drugs Product
Table 194. Teva Recent Development
Table 195. Otsuka Corporation Information
Table 196. Otsuka Description and Business Overview
Table 197. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Otsuka Cancer Treatment Drugs Product
Table 199. Otsuka Recent Development
Table 200. Merck KGaA Corporation Information
Table 201. Merck KGaA Description and Business Overview
Table 202. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 203. Merck KGaA Cancer Treatment Drugs Product
Table 204. Merck KGaA Recent Development
Table 205. Ipsen Corporation Information
Table 206. Ipsen Description and Business Overview
Table 207. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 208. Ipsen Cancer Treatment Drugs Product
Table 209. Ipsen Recent Development
Table 210. AbbVie Corporation Information
Table 211. AbbVie Description and Business Overview
Table 212. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 213. AbbVie Cancer Treatment Drugs Product
Table 214. AbbVie Recent Development
Table 215. Gilead Sciences Corporation Information
Table 216. Gilead Sciences Description and Business Overview
Table 217. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 218. Gilead Sciences Cancer Treatment Drugs Product
Table 219. Gilead Sciences Recent Development
Table 220. Production Base and Market Concentration Rate of Raw Material
Table 221. Key Suppliers of Raw Materials
Table 222. Cancer Treatment Drugs Distributors List
Table 223. Cancer Treatment Drugs Customers List
Table 224. Cancer Treatment Drugs Market Trends
Table 225. Cancer Treatment Drugs Market Drivers
Table 226. Cancer Treatment Drugs Market Challenges
Table 227. Cancer Treatment Drugs Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Treatment Drugs Product Picture
Figure 2. Global Cancer Treatment Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cancer Treatment Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Blood Cancer Examples
Figure 7. Breast Cancer Examples
Figure 8. Gastrointestinal Cancer Examples
Figure 9. Prostate Cancer Examples
Figure 10. Respiratory/Lung Cancer Examples
Figure 11. Others Examples
Figure 12. Global Cancer Treatment Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cancer Treatment Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Cancer Treatment Drugs Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Cancer Treatment Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Cancer Treatment Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Cancer Treatment Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Cancer Treatment Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Cancer Treatment Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Cancer Treatment Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Cancer Treatment Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Cancer Treatment Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Cancer Treatment Drugs Players Market Share by Revenue in Cancer Treatment Drugs: 2016 & 2020
Figure 31. Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Cancer Treatment Drugs Revenue Share by Type (2016-2021)
Figure 33. Global Cancer Treatment Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Cancer Treatment Drugs Revenue Share by Application (2016-2021)
Figure 35. Global Cancer Treatment Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Cancer Treatment Drugs Sales Market Share by Type in 2020
Figure 37. North America Cancer Treatment Drugs Sales Market Share by Application in 2020
Figure 38. Europe Cancer Treatment Drugs Sales Market Share by Type in 2020
Figure 39. Europe Cancer Treatment Drugs Sales Market Share by Application in 2020
Figure 40. China Cancer Treatment Drugs Sales Market Share by Type in 2020
Figure 41. China Cancer Treatment Drugs Sales Market Share by Application in 2020
Figure 42. Japan Cancer Treatment Drugs Sales Market Share by Type in 2020
Figure 43. Japan Cancer Treatment Drugs Sales Market Share by Application in 2020
Figure 44. Southeast Asia Cancer Treatment Drugs Sales Market Share by Type in 2020
Figure 45. Southeast Asia Cancer Treatment Drugs Sales Market Share by Application in 2020
Figure 46. India Cancer Treatment Drugs Sales Market Share by Type in 2020
Figure 47. India Cancer Treatment Drugs Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Cancer Treatment Drugs
Figure 50. Manufacturing Process Analysis of Cancer Treatment Drugs
Figure 51. Cancer Treatment Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Market Analysis and Insights: Global Cancer H…- 世界の食道がん治療薬市場規模・現状・予測（2021年-2027年） Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a …
- 世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 世界のがん支持療法薬剤市場規模・現状・予測（2021年-2027年） Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy. Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailore…
- 世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Treatment Market The global Anaplastic T…